Anticarcinoma antibodies and uses thereof

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 47/48 (2006.01) C07K 16/30 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2547034

There is disclosed herein an amino acid sequence comprising DVQLQASGGG X1,VQPGGSLRL SCAAHDPIFD KNLMGWX2RQA PGKX3X4EX5VAT ISGSGGTNYA SSVEGRFTIS RDNAKKTVYL QMNDLKPEDT AVYYCNSAFA IX6GQGTQVTV SS Wherein Xl is: V, S, D, L, F, W, or T; X2 is: G, F, Y, V, I, H, or L; X3 is: Q, G, E, D, L, R, or K; X4 is: R, C, Q, L, I, P, or K; X5 is: Y, T, A, W, F, S, or L; X6 is: W, R, E, A, G, V, or K. This sequence is useful in the production of antibodies and other proteins capable of recognizing cancer-specific antigens.

L'invention porte sur la séquence d'acides aminés: X¿1?,VQPGGSLRL SCAAHDPIFD KNLMGWX¿2?RQA PGKX¿3?X¿4?EX¿5?VAT ISGSGGTNYA SSVEGRFTIS RDNAKKTVYL QMNDLKPEDT AVYYCNSAFA IX¿6?GQGTQVTV SS, dans laquelle: X¿l? est: V, S, D, L, F, W, ou T; X¿2? est: G, F, Y, V, I, H, ou L; X¿3? ¿is: ?Q, G, E, D, L, R, ou K; X¿4? est: R, C, Q, L, I, P, ou K; X¿5? est: Y, T, A, W, F, S, ou L; et X¿6? est: W, R, E, A, G, V, ou K. Cette séquence est utile pour la production d'anticorps et d'autres protéines, capables de reconnaître les antigènes spécifiques du cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anticarcinoma antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticarcinoma antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticarcinoma antibodies and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2026553

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.